Electra Therapeutics
Pioneering next-generation immunology therapeutics.
South San Francisco, United States · Founded 2018 · $267.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- electra-therapeutics.com
- Total Funding
- $267.0M
- Last Round
- $183.0M Series COct 2025
- Rounds
- 2
About
Clinical-stage biotech developing SIRP-targeting therapies for autoimmune diseases and cancer with unmet medical needs.
Summary
Electra Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2018. It has raised $267.0M in total across 2 rounds, most recently a $183.0M Series C round in Oct 2025. Investors include EQT AB, Nextech Invest and Westlake Village BioPartners.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company